Lipocine Inc
F:2VT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lipocine Inc
F:2VT
|
US |
|
Essential Properties Realty Trust Inc
F:2OU
|
US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
US |
|
C
|
CrowdStrike Holdings Inc
F:45C
|
US |
|
A
|
Air Products and Chemicals Inc
F:AP3
|
US |
|
T
|
Tutor Perini Corp
F:PE2
|
US |
|
C
|
Computacenter PLC
F:COUD
|
UK |
|
I
|
Interpublic Group of Companies Inc
XMUN:IPG
|
US |
|
N
|
Nov Inc
F:NO8
|
US |
|
Tesmec SpA
MIL:TES
|
IT |
|
K
|
Kawasaki Heavy Industries Ltd
XMUN:KHE
|
JP |
|
G
|
GFPT PCL
SET:GFPT
|
TH |
|
Roper Technologies Inc
SIX:ROP
|
US |
|
E
|
EDP Energias de Portugal SA
ELI:EDP
|
PT |
|
B
|
Basic Fit NV
SWB:B4F
|
NL |
|
EchoStar Corp
NASDAQ:ECHO
|
US |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
F:MUVB
|
DE |
|
Cedar Woods Properties Ltd
ASX:CWP
|
AU |
Wall St Price Targets
2VT Price Targets Summary
Lipocine Inc
According to Wall Street analysts, the average 1-year price target for
2VT is 10.032 EUR with a low forecast of 9.934 EUR and a high forecast of 10.327 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2VT's stock price target?
Price Target
10.032
EUR
According to Wall Street analysts, the average 1-year price target for
2VT is 10.032 EUR with a low forecast of 9.934 EUR and a high forecast of 10.327 EUR.
What is the Revenue forecast for Lipocine Inc?
Projected CAGR
112%
The compound annual growth rate for Revenue over the next 5 years is 112%.